Olpen-F

Description

Olpen-F is an ANVIS capsule product labelled olanzapine and fluoxetine hydrochloride, 3 mg / 25 mg. The photographed carton contains thirty capsules. This entry identifies the combination and distinguishes it from single-ingredient olanzapine or fluoxetine products.

Olpen-F product specification

• Labelled ingredients: Olanzapine and fluoxetine hydrochloride
• Strength information: Olanzapine 3 mg / fluoxetine 25 mg per capsule, as labelled
• Dosage form: Capsules
• Pack presentation: 3 × 10 capsules (30 capsules)
• Brand: ANVIS

Ingredient background

Olanzapine and fluoxetine combine an antipsychotic medicine with an antidepressant. The combination has uses in selected depressive conditions, including bipolar depression and treatment-resistant depression. However, a qualified clinician must assess the diagnosis and choose treatment. The pack name alone cannot determine suitability.

Important precautions

Read the warning about increased suicidal thoughts and behaviour in younger people taking antidepressants. Seek prompt professional help for new or worsening mood changes. Also read the warning about increased mortality in older people with dementia-related psychosis. This combination is not approved for that purpose.

The medicine may cause drowsiness and changes in weight, blood sugar or blood lipids. Therefore, discuss monitoring and other medicines with the prescriber. Do not combine it with an MAOI. Also ask before drinking alcohol, driving or changing treatment. Follow the full leaflet and clinician’s directions.

Checking strength and presentation

The two numbers refer to different ingredients in the same capsule. First, match the 3 mg / 25 mg presentation with the prescription. Do not compare it with another product by looking at only one number. In addition, confirm the complete label if a supplied pack uses different wording.

The thirty-capsule count describes the carton quantity. It does not specify a dose, a treatment duration or the right time to take the medicine. Before use, check the seal, batch details and expiry date. Also keep the carton and leaflet together so that their identification and instructions remain available.

Documentation and enquiries

For general ingredient background, read the DailyMed olanzapine and fluoxetine prescribing information. However, that source does not confirm the full specification of this ANVIS product. For further documentation or availability, contact ANVIS with the exact product name and presentation. Alternatively, browse the ANVIS product catalogue to compare other products.